Two Sigma Securities’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-216
Closed -$246K 1404
2019
Q4
$246K Buy
+216
New +$235K ﹤0.01% 1932
2019
Q3
Sell
-340
Closed -$560K 2063
2019
Q2
$560K Buy
+340
New +$588K 0.01% 1049

Other funds holding BLUE

Two Sigma Securities's BLUE Position: Q1 2023 in Review

Two Sigma Securities sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 734 shares — an estimated $102K sold.

Two Sigma Securities first reported a position in BLUE in Q1 2017 and held it in 6 quarters. The position peaked at $1.32M in Q2 2017. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • Two Sigma Securities reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 734 bluebird bio shares in Q1 2023, an estimated $102K.
  • Two Sigma Securities first reported a position in bluebird bio in Q1 2017 and held it in 6 quarters.
  • Two Sigma Securities's bluebird bio position peaked at $1.32M in Q2 2017.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.